James Goldfeier’s practice focuses on merger investigations, merger analysis and antitrust counselling. He has worked on merger investigations brought by both the FTC and the DOJ. James’s merger experience includes, most notably, Dell Technologies’ $67 billion acquisition of EMC Corporation; Ball Corporation’s $6.85 billion acquisition of Rexam PLC; and Thermo Fisher Scientific’s $13.6 billion acquisition of Life Technologies. He is currently on the team serving as global lead antitrust counsel to Thermo Fisher in its US$11.5 billion acquisition of QIAGEN NV.
James currently serves on the selective executive committee of the antitrust section of the New York State Bar Association. James previously served as chair and vice chair of the section's mergers committee. He also volunteers his time as a member of the Harvard Club of New York City schools committee, conducting alumni interviews of prospective students of Harvard College. In 2017, the New York State Bar recognised James as an “Empire State Counsel” for his pro bono contributions to the New York community.
At Columbia Law School, James was a founding member and later president of the Columbia International Antitrust Law Association. Prior to Axinn, James worked as a judicial intern for Justice Shirley Werner Kornreich of the commercial division of the New York State Supreme Court, New York County.